Finland has made its first specific commitment to the development of European biomedical research infrastructures (BMS ESFRIs) by supporting a joint pilot infrastructure project in bioinformatics (ELIXIR), biobanking (BBMRI) and translational research (EATRIS). The initial commitment of 1.85 M is to support preparation and pilot studies in 2010.
This funding is meant to ensure Finland's commitment to the building of these European infrastructures. The level of funding in the future years was left open as this depends on the outcome and structures that will be developed in the pilot phase.
The approach that Finland has selected is based on the realization that significant potential synergies may arise from infrastructures developed for biobanking, bioinformatics and translational medical research. Funding of 1 M is provided by the Ministry of Education through the Academy of Finland, with 0.85 M co-financing from the consortium consisting of the Institute for Molecular Medicine Finland (FIMM), CSC IT Center for Science Ltd and the National Institute for Health and Welfare (THL).
This project is meant to ensure that Finnish scientists and institutions will continue to be active in the planning and implementation of the first wave of European BMS ESFRI infrastructures. There is particular interest to form links and synergies between the infrastructures, such as by linking sustainable infrastructure for biological information (ELIXIR) with biomedical samples and clinical, life-style and environmental data (BBMRI) as well as an opportunity to translate results to diagnostic and biomarker purposes (EATRIS).
Professor Olli Kallioniemi, the director of FIMM and coordinator of the collaboration between the three infrastructure efforts, says "A small country should concentrate its investments in the European dimension to those areas that are of critical importance and where synergies may be arise. Finland has a long tradition of
|Contact: Dr. Olli Kallioniemi|
University of Helsinki